InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: None

Monday, 02/08/2016 12:01:48 PM

Monday, February 08, 2016 12:01:48 PM

Post# of 48316
Presentation Stated Development Milestones: Key Value Drivers Over the Next 12 months

--Announce new key academic or industry collaborations

--Expand POC Phase II melanoma combo study sites, complete enrollment and present preliminary clinical data

--Complete TNBC biomarker study as POC in breast cancer, present interim data and finalize development plan

--Announce novel “multi-gene” combination ImmunoPulse candidate

--Present pre-clinical combination data with Heat Biologics